A detailed history of Steward Partners Investment Advisory, LLC transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 4,160 shares of SLGL stock, worth $2,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,160
Previous 4,160 -0.0%
Holding current value
$2,246
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.92 - $1.6 $1,840 - $3,200
-2,000 Reduced 32.47%
4,160 $4,000
Q3 2023

Nov 13, 2023

SELL
$1.63 - $3.94 $163 - $394
-100 Reduced 1.6%
6,160 $10,000
Q4 2022

Feb 15, 2023

SELL
$4.26 - $5.22 $6,390 - $7,830
-1,500 Reduced 19.33%
6,260 $28,000
Q3 2022

Nov 10, 2022

SELL
$4.16 - $6.4 $4,160 - $6,400
-1,000 Reduced 11.42%
7,760 $39,000
Q2 2022

Aug 04, 2022

BUY
$4.1 - $7.36 $409 - $736
100 Added 1.15%
8,760 $36,000
Q4 2021

Feb 08, 2022

SELL
$6.57 - $9.78 $3,285 - $4,890
-500 Reduced 5.46%
8,660 $64,000
Q3 2021

Nov 12, 2021

BUY
$8.85 - $12.5 $4,425 - $6,250
500 Added 5.77%
9,160 $91,000
Q1 2020

Apr 29, 2020

BUY
$5.88 - $15.75 $8,820 - $23,625
1,500 Added 20.95%
8,660 $61,000
Q4 2019

Jan 17, 2020

SELL
$7.5 - $17.15 $4,425 - $10,118
-590 Reduced 7.61%
7,160 $122,000
Q2 2019

Jul 25, 2019

BUY
$6.78 - $9.49 $52,545 - $73,547
7,750 New
7,750 $70,000
Q4 2018

Jan 15, 2019

SELL
$5.79 - $8.1 $52,191 - $73,013
-9,014 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$6.2 - $7.8 $11,718 - $14,742
1,890 Added 26.53%
9,014 $68,000
Q2 2018

Jul 20, 2018

BUY
$7.5 - $10.71 $37,042 - $52,896
4,939 Added 226.04%
7,124 $55,000
Q1 2018

Apr 20, 2018

BUY
$10.3 - $13.64 $22,505 - $29,803
2,185 New
2,185 $22,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $12.5M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.